Nephros, Inc. has introduced a new S100 In-Line microfilter designed to provide enhanced installation flexibility for bacterial retention in medical and non-clinical settings. The innovative filter extends the company's existing S100 microfiltration line, addressing critical water safety needs across multiple industries.
The new in-line model supports bacterial remediation in environments previously challenging for traditional filtration, including emergency eyewash stations, pharmaceutical laboratories, dental equipment, and recreational vehicle water systems. Maintaining the S100 product line's rigorous performance standards, the filter features a 0.1-micron pore size, FDA 510(k) clearance as a Class II medical device, and bacterial retention performance meeting ASTM F838 standards.
Key features of the microfilter include an increased flow rate, a 90-day filter life, and two configuration options—Quick Connect and Threaded—to accommodate diverse installation requirements. The product represents a strategic expansion of Nephros' water filtration portfolio, bridging functional gaps between microfiltration and ultrafiltration product lines.
Robert Banks, President and CEO of Nephros, emphasized the filter's practical significance, noting that it enables the company to address specific installation scenarios where conventional filtration methods prove inadequate. The launch underscores Nephros' commitment to developing adaptable water safety solutions that meet evolving industry needs.
The S100 In-Line microfilter's versatility positions Nephros to serve a broader range of customers across medical, commercial, and industrial markets, potentially improving water quality and infection control in critical environments.
